Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)

Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 2

Abstract

.

Authors and Affiliations

Esme Ekizoğlu

Keywords

Related Articles

Evaluation of Behavior, Learning, Memory Along with Apoptosis, Neuronal Damage, and GABA-A Alpha-1 Receptor Level After Status Epilepticus in Immature and Mature Rats

Objective: In this study, we aimed to evaluate age-dependent cognitive and behavioral changes, neuronal damage, and the amount of gamma-aminobutyric acid-A (GABA-A) alpha 1 in immature, mature, and adolescant rats after...

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments

Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is caused by gain-of-toxic-function of TTR, which dissociates from its native tetramer form to a monomer form and aggregates in several tissues and organs....

Evaluation of Seizure After Stroke in Stroke Unit

Objective: Patients with stroke may experience epileptic seizures as acute phase (usually defined as the first 15 days) or late phase complications. Risk factors are young age, male sex, cortical involvement and hemorrha...

Download PDF file
  • EP ID EP368890
  • DOI 10.4274/tnd.37233
  • Views 91
  • Downloads 0

How To Cite

Esme Ekizoğlu (2018). Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study). UNKNOWN, 24(2), 199-200. https://europub.co.uk./articles/-A-368890